BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6859073)

  • 1. New perspectives on therapeutic application of nitrates as vasodilator agents for severe chronic heart failure.
    Packer M
    Am J Med; 1983 Jun; 74(6B):61-72. PubMed ID: 6859073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrates in congestive heart failure.
    Dupuis J
    Cardiovasc Drugs Ther; 1994 Jun; 8(3):501-7. PubMed ID: 7947367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients.
    Ormerod JO; Arif S; Mukadam M; Evans JD; Beadle R; Fernandez BO; Bonser RS; Feelisch M; Madhani M; Frenneaux MP
    Circ Heart Fail; 2015 May; 8(3):565-71. PubMed ID: 25838311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
    Franciosa JA; Cohn JN
    Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects on "traditional" vasodilators in the treatment of chronic heart failure.
    Rydén L; Conradson TB
    Acta Med Scand Suppl; 1986; 707():85-90. PubMed ID: 3526822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nitrates in heart failure: the hemodynamic effects and clinical implications].
    Faggiano P; Rusconi C; Ghizzoni G
    Cardiology; 1994; 84 Suppl 1():52-63. PubMed ID: 8087825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
    Packer M; Medina N; Yushak M
    Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
    Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
    Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
    Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
    Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrates for congestive heart failure.
    Cohn JN
    Am J Cardiol; 1985 Jul; 56(2):19A-23A. PubMed ID: 4014049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrate therapy in angina and congestive heart failure.
    Vlay SC; Cohn PF
    Cardiology; 1985; 72(5-6):322-8. PubMed ID: 3907832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of nitroglycerin and long-acting nitrates.
    Abrams J
    Am Heart J; 1985 Jul; 110(1 Pt 2):216-24. PubMed ID: 3925741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M; Lee WH
    Am J Cardiol; 1986 Feb; 57(4):260-7. PubMed ID: 3080861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilator therapy.
    Sutton FJ
    Am J Med; 1986 Feb; 80(2B):54-8. PubMed ID: 3511697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilators in left ventricular failure.
    Camerini F; Mestroni L; Neri R; Humar F
    G Ital Cardiol; 1984 Sep; 14(9):685-93. PubMed ID: 6510623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action and efficacy of nitrates in heart failure.
    Cohn JN
    Am J Cardiol; 1992 Sep; 70(8):88B-92B. PubMed ID: 1529931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy.
    Packer M; Meller J; Medina N; Yushak M; Gorlin R
    Circulation; 1981 Sep; 64(3):506-14. PubMed ID: 7261283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrates in the treatment of congestive heart failure.
    Elkayam U
    Am J Cardiol; 1996 May; 77(13):41C-51C. PubMed ID: 8638526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conceptual dilemmas in the classification of vasodilator drugs for severe chronic heart failure. Advocacy of a pragmatic approach to the selection of a therapeutic agent.
    Packer M
    Am J Med; 1984 Jun; 76(6A):3-13. PubMed ID: 6377886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.